Rexer Pharma Private Limited, a active private limited company, was established on 20 December 1996 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230TG1996PTC026005. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹4.00 M.
It upholds a compliant status. Employing 16 professional, Its leadership includes Sujana Seelam (Director), Madallapalli Surya Mohan (Director), Raghava Reddy Gureddygari (Director). Past directors included Sujana Seelam, Seelam Sreenivas Reddy. It holds no open charges and ₹1.51 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 114/2/B, Phase-Ii, Ida, Cherlapally, Hyderabad, Telangana, 500051.
U24230TG1996PTC026005
026005
20 December 1996
₹4.00 M
₹4.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Rexer Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujana Seelam | Director | 23 Jan 2017 | Current |
| Madallapalli Surya Mohan | Director | 20 Dec 1996 | Current |
| Raghava Reddy Gureddygari | Director | 20 Dec 1996 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Director | 29 Jul 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rexer Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.09% increase. The company also saw a substantial improvement in profitability, with a 53.15% increase in profit. The company's net worth moved up by a moderate rise of 1.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Rexer Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹15,100,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Mar 2016 | Others | ₹1.50 M | Satisfied |
| 30 Mar 2010 | Andhra Pradesh State Financial Corporation | ₹4.00 M | Satisfied |
| 20 Jul 2007 | Others | ₹2.00 M | Satisfied |
| 18 Mar 2005 | A. P. State Financial Corporation | ₹7.60 M | Satisfied |
Explore comprehensive loan charge details -
Rexer Pharma has a workforce of 16 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rexer Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rexer Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rexer Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Rexer Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Progress on A charge registered on 09 Mar 2016 via Charge ID 100022033 with Others was fully satisfied on 27 Oct 2023. was documented.
A charge registered on 20 Jul 2007 via Charge ID 10097532 with Others was fully satisfied on 27 Oct 2023. was recorded as a recent event.
Progress on Sujana Seelam was appointed as a Director was appointed as a Director on 23 Jan 2017 & has been associated with this company since 8 years 10 months . was documented.
A charge registered on 30 Mar 2010 via Charge ID 10213732 with Andhra Pradesh State Financial Corporation was fully satisfied on 18 Apr 2016. was recorded as a recent event.
The CIN of Rexer Pharma Private Limited is U24230TG1996PTC026005.
Rexer Pharma Private Limited is headquartered at 114/2/B, Phase-Ii, Ida, Cherlapally, Hyderabad, Telangana, 500051.
Rexer Pharma Private Limited was incorporated on 20 December 1996.
The current directors of Rexer Pharma Private Limited are
The primary industry of Rexer Pharma Private Limited is Manufacturing.
Rexer Pharma Private Limited is unlisted.
The authorized capital of Rexer Pharma Private Limited is ₹4.00 M, and the paid-up capital is ₹4.00 M.
The compliance status of Rexer Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX